Status:
WITHDRAWN
Risk Factors for Drusen Progression
Lead Sponsor:
Medical University of Vienna
Conditions:
Age-related Macular Degeneration
Eligibility:
All Genders
50+ years
Brief Summary
Age-related macular degeneration (AMD) is the leading cause of blindness in the Western World. The etiology and pathogenesis of this disease remain largely unknown. In Europe about two million people ...
Eligibility Criteria
Inclusion
- Men and postmenopausal women aged ≥ 50 years
- AREDS categories 2 or 3 in at least one of the eyes
- No ocular surgery within last 6 months
Exclusion
- Late form of AMD in one or two eyes (AREDS category 4)
- Moderate or severe non-proliferative diabetic retinopathy, proliferative diabetic retinopathy
- Clinically significant macular edema
- Macular or peripheral retinal dystrophies
- Ocular surgery other than uncomplicated cataract surgery
- Opacity of the ocular media by cornea or lens or diseases, which could potentially influence scan quality
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01830608
Start Date
January 1 2015
End Date
March 1 2015
Last Update
April 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Vienna, Austria, 1090